Acute myeloid leukaemia and Paroxysmal supraventricular tachycardia

Summary:

Paroxysmal supraventricular tachycardia is found among people with Acute myeloid leukaemia, especially for people who are male, 60+ old.

The study analyzes which people have Paroxysmal supraventricular tachycardia with Acute myeloid leukaemia. It is created by eHealthMe based on reports of 82 people who have Acute myeloid leukaemia from the Food and Drug Administration (FDA), and is updated regularly. You can use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.



On Nov, 30, 2022

82 people who have Acute Myeloid Leukaemia and Paroxysmal Supraventricular Tachycardia are studied.


What is Acute myeloid leukaemia?

Acute myeloid leukaemia (acute cancer in which the bone marrow makes abnormal myeloblasts) is found to be associated with 1,308 drugs and 957 conditions by eHealthMe.

What is Paroxysmal supraventricular tachycardia?

Paroxysmal supraventricular tachycardia is found to be associated with 2,327 drugs and 1,621 conditions by eHealthMe.

Number of Paroxysmal supraventricular tachycardia in Acute myeloid leukaemia reports submitted per year:

Would you have Paroxysmal supraventricular tachycardia when you have Acute myeloid leukaemia?

Gender of people who have Acute Myeloid Leukaemia and experienced Paroxysmal Supraventricular Tachycardia *:

  • female: 44.44 %
  • male: 55.56 %

Age of people who have Acute Myeloid Leukaemia and experienced Paroxysmal Supraventricular Tachycardia *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 1.28 %
  • 20-29: 2.56 %
  • 30-39: 2.56 %
  • 40-49: 2.56 %
  • 50-59: 25.64 %
  • 60+: 65.38 %

Common co-existing conditions for these people *:

  1. Constipation: 8 people, 9.76%
  2. High Blood Pressure: 6 people, 7.32%
  3. Haemorrhoids (a swollen vein or group of veins in the region of the anus): 5 people, 6.10%
  4. Tumor Lysis Syndrome: 4 people, 4.88%
  5. Cardiac Disorder: 4 people, 4.88%
  6. Erection Problems: 3 people, 3.66%
  7. Insomnia (sleeplessness): 3 people, 3.66%
  8. Urinary Retention (the inability to completely or partially empty the bladder): 3 people, 3.66%
  9. Gingivitis (inflammation of gums): 3 people, 3.66%
  10. Fever: 3 people, 3.66%

Common drugs taken by these people *:

  1. Cytarabine: 18 people, 21.95%
  2. Mylotarg: 18 people, 21.95%
  3. Acyclovir: 13 people, 15.85%
  4. Diflucan: 11 people, 13.41%
  5. Ondansetron: 8 people, 9.76%
  6. Cipro: 8 people, 9.76%
  7. Remeron: 8 people, 9.76%
  8. Vidaza: 8 people, 9.76%
  9. Augmentin: 7 people, 8.54%
  10. Pantoprazole: 7 people, 8.54%

Common symptoms for these people *:

  1. Febrile Neutropenia (fever with reduced white blood cells): 24 people, 29.27%
  2. Hypotension (abnormally low blood pressure): 20 people, 24.39%
  3. Thrombocytopenia (decrease of platelets in blood): 17 people, 20.73%
  4. Pleural Effusion (water on the lungs): 17 people, 20.73%
  5. Atelectasis (partial or complete collapse of the lung): 17 people, 20.73%
  6. Sepsis (a severe blood infection that can lead to organ failure and death): 17 people, 20.73%
  7. Pneumonia: 15 people, 18.29%
  8. Diarrhea: 15 people, 18.29%
  9. Fatigue (feeling of tiredness): 12 people, 14.63%
  10. Aspartate Aminotransferase Increased: 11 people, 13.41%

* Approximation only. Some reports may have incomplete information.

Do you take medications and have Paroxysmal supraventricular tachycardia?

Check whether Paroxysmal supraventricular tachycardia is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.



Related studies

Treatments, associated drugs and conditions:

COVID vaccines that are related to Paroxysmal supraventricular tachycardia:

Common drugs associated with Paroxysmal supraventricular tachycardia:

All the drugs that are associated with Paroxysmal supraventricular tachycardia:

Common conditions associated with Paroxysmal supraventricular tachycardia:

All the conditions that are associated with Paroxysmal supraventricular tachycardia:

How the study uses the data?

The study is based on Paroxysmal supraventricular tachycardia and Acute myeloid leukaemia, and their synonyms.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: